Novel Moa Major Depressive Disorder Equipment & Supplies

1 equipment items found

Novel MOA - Model REL-1017 - Novel N-methyl-D-Aspartate Receptor (NMDAR) Channel Blocker

by:Relmada Therapeutics, Inc. based inCoral Gables, FLORIDA (USA)

REL-1017 is a novel N-methyl-D-aspartate receptor (NMDAR) channel blocker in phase 3 clinical trials for the treatment of Major Depressive Disorder (MDD). REL-1017 works with a MOA markedly different from standard serotoninergic ...

CONTACT SUPPLIER

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you